Bio Pharma Dive

JUNE 27, 2024

A growing cohort of biotechs, from Biohaven to Neurocrine to Jazz, hope research on ion channels will bring them new drugs and big business — much like it has done for Vertex.

Medicine 345

Medicine Drugs Research 345

Bio Pharma Dive

MAY 12, 2025

Explore the cutting-edge of science and learn how Danaher is advancing healthcare innovation

Medicine 147

Medicine 147

Pharmaceutical Technology

MAY 26, 2025

The European Medicines Agencys (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of GSKs Blenrep.

Medicine 233

Medicine Production 233

Scienmag

JUNE 10, 2025

In a groundbreaking development that promises to accelerate drug discovery and pharmaceutical research, Insilico Medicine, a leading clinical-stage biotechnology company harnessing generative artificial intelligence, has announced the launch of its latest foundation model, Nach01, on Amazon Web Services (AWS).

Medicine 75

Medicine Drugs Research Development 75

Bio Pharma Dive

JUNE 11, 2025

The startup, which is backed by the venture arms of Sanofi, Roche and Novartis, is using dual adeno-associated viruses to help overcome the packaging constraints of current genetic medicines.

Gene Therapy 242

Gene Therapy Packaging Packaging Gene 242

Pharmaceutical Technology

MAY 9, 2025

HLS Therapeutics has signed an agreement with Esperion Therapeutics for commercialising Nexletol and Nexlizet in Canada.

Medicine 130

Medicine 130

Bio Pharma Dive

JULY 15, 2024

Updated results show the biotech's RAS inhibitor shrank pancreatic tumors in 20% to 25% of study participants, but with high rates of side effects like rash and nausea.

Medicine 322

Medicine Trials Drugs 322

Bio Pharma Dive

JUNE 17, 2025

The deal centers around a medicine that could “shift the treatment paradigm for cardiovascular disease,” Lilly said, but also follows a yearslong in decline in Verve’s share price amid skepticism over the need for such a therapy.

Gene Editing 194

Gene Editing Gene Medicine 194

Bio Pharma Dive

MAY 6, 2025

A vocal opponent of his predecessor Peter Marks, Vinay Prasad will now lead the office tasked with reviewing some genetic medicines, adding more uncertainty to an already struggling field of research.

Gene Therapy 209

Gene Therapy Gene Genetics Medicine 209

Bio Pharma Dive

MAY 15, 2025

ADARx Pharmaceuticals will work with AbbVie to make RNA interference medicines for a variety of disease areas, including neurology, immunology and cancer.

RNA 157

RNA Drugs Medicine 157

BioTech 365

JUNE 23, 2025

European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept) European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept) REYKJAVIK, ICELAND and LONDON, UK (June 23, 2025) — Alvotech (NASDAQ: ALVO), a … Continue reading →

52

52

Medical Xpress

JUNE 16, 2025

A research team from the School of Clinical Medicine of the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) has pioneered the use of a 'dual immunotherapy' combination—nivolumab and ipilimumab (NIVO+IPI)—in the treatment of liver cancer patients since 2016.

Medicine 122

Medicine Research 122

Rethinking Clinical Trials

MAY 12, 2025

Hernandez, who serves as coprincipal investigator of the NIH Pragmatic Trials Collaboratory Coordinating Center, is a professor of medicine and vice dean in the Duke University School of Medicine and executive director of the Duke Clinical Research Institute. Spaeder is the chief medical and scientific officer at IQVIA.

Clinical Trials 163

Clinical Trials Clinical Trials Trials Clinical Research 163

Rethinking Clinical Trials

NOVEMBER 13, 2024

Delgado is an associate professor of emergency medicine and epidemiology at the University of Pennsylvania and the director of the Penn Medicine Nudge Unit, which “designs and implements scalable nudges to improve medical decision-making and patient outcomes.” ” Join the online meeting.

Trials 174

Trials Clinical Trials Clinical Trials Medicine 174

Rethinking Clinical Trials

DECEMBER 11, 2024

Gbenga Ogedegbe In this Friday’s PCT Grand Rounds, Gbenga Ogedegbe of the NYU Grossman School of Medicine will present “Home Blood Pressure Telemonitoring and Nurse Case Management in Black and Hispanic Patients With Stroke: A Randomized Clinical Trial.” Join the online meeting.

Clinical Trials 148

Clinical Trials Clinical Trials Nurses Medicine 148

Pharmaceutical Technology

MAY 28, 2025

The US FDA has granted regenerative medicine advanced therapy (RMAT) designation to AbelZeta Pharmas C-CAR168.

Medicine 130

Medicine 130

Bio Pharma Dive

MAY 2, 2025

Sales of the company’s copycat to J&J’s blockbuster medicine reached $150 million in the first quarter, adding to a surge in revenue for Amgen's biosimilar business.

Sales 176

Sales Medicine 176

Bio Pharma Dive

JUNE 17, 2025

The agency cleared CSL’s hereditary angioedema drug days after “resource constraints” delayed a rival medicine. Elsewhere, Intellia revealed new data and Lilly beefed up an online service offering access to Zepbound.

Drugs 144

Drugs Medicine 144

Rethinking Clinical Trials

FEBRUARY 12, 2025

Volandes is a professor of medicine at the Geisel School of Medicine at Dartmouth and the vice chair for research in the Department of Medicine at Dartmouth Health. Tulsky is a professor of medicine at Harvard Medical School and the Poorvu Jaffe Chair of Supportive Oncology at the Dana-Farber Cancer Institute.

Trials 148

Trials Medicine Clinical Trials Clinical Trials 148

Bio Pharma Dive

OCTOBER 22, 2024

Early study data from Wave Life Sciences suggests how editing RNA may yield viable medicines. Large and small drugmakers say such results are just the start.

RNA 354

RNA Life Science Medicine 354

STAT News

JUNE 20, 2025

The study, presented Friday at the American Diabetes Association’s scientific meeting and simultaneously published in the New England Journal of Medicine , updates previous research that followed these participants for a shorter period of time. After 12 months, out of the 12 participants, 10 no longer needed to inject insulin.

Insulin 144

Insulin Medicine Research 144

Medical Xpress

MARCH 7, 2025

Published in npj Regenerative Medicine, the study reveals a novel approach to promoting cardiomyocyte proliferation. DeBakey Department of Surgery at Baylor College of Medicine, the QIMR Berghofer Medical Research Institute in Brisbane, Australia, and collaborating institutions. The researchers are from the Michael E.

Medicine 138

Medicine Research 138

Bio Pharma Dive

SEPTEMBER 4, 2024

Over the past 10 years, PD1-blocking medicines have transformed cancer care. But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes.

Drugs 350

Drugs Medicine 350

Rethinking Clinical Trials

APRIL 2, 2025

Heerman is an associate professor of internal medicine and pediatrics, the William K. Warren Foundation Chair in Medicine, and chief of the Division of Academic General Pediatrics at Vanderbilt University Medical Center. ” The Grand Rounds session will be held on Friday, April 4, 2025, at 1:00 pm eastern. Join the online meeting.

Trials 148

Trials Clinical Trials Clinical Trials Medicine 148

Pharmaceutical Technology

MAY 12, 2025

The new site will support Roche and its unit Genentech's future portfolio of next-generation obesity medicines.

Manufacturing 130

Manufacturing Medicine 130

Rethinking Clinical Trials

MARCH 19, 2025

Blood is an instructor of medicine and associate director of the Accelerator for Clinical Transformation Research Group at Harvard Medical School and a cardiologist and intensivist at Brigham and Women’s Hospital. ” The Grand Rounds session will be held on Friday, March 21, 2025, at 1:00 pm eastern.

Clinical Trials 201

Clinical Trials Clinical Trials Trials Medicine 201

Rethinking Clinical Trials

JANUARY 29, 2025

Skolasky is a professor of orthopaedic surgery and the director of the Spine Outcomes Research Center, and McLaughlin is an assistant professor of physical medicine and rehabilitationboth at the Johns Hopkins University School of Medicine. Join the online meeting.

Trials 174

Trials Clinical Trials Clinical Trials Medicine 174

Bio Pharma Dive

JUNE 9, 2025

Early-stage study results suggest that a single shot of the company’s therapy, which works differently than GLP-1 medicines, might have effects that last at least four weeks.

Medicine 144

Medicine 144

Bio Pharma Dive

JANUARY 7, 2025

Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the tally of failed drugs in the innovative “Healey platform trial” to seven.

Life Science 326

Life Science Trials Drugs Medicine 326

Rethinking Clinical Trials

JANUARY 8, 2025

Join the online meeting.

Trials 183

Trials Clinical Trials Clinical Trials Medicine 183

Bio Pharma Dive

APRIL 8, 2024

But many development hurdles still stand in the way of new medicines for the brain. Recent biotech company acquisitions have put emerging schizophrenia treatments in focus.

Medicine 343

Medicine Drugs Development 343

Pharmaceutical Technology

MAY 2, 2025

4D Molecular Therapeutics (4DMT) has received the regenerative medicine advanced therapy (RMAT) designation from the FDA for 4D-150.

Medicine 130

Medicine 130

Bio Pharma Dive

NOVEMBER 14, 2024

The company is paying China-based biotech LaNova Medicines $588 million for the type of dual-pronged antibody drug that recently bested Keytruda in a clinical trial.

Clinical Trials 312

Clinical Trials Clinical Trials Antibody Medicine 312

Bio Pharma Dive

JULY 11, 2024

Far behind companies like Novo and Eli Lilly, Pfizer hopes the version of the drug, danuglipron, that it’s chosen to advance can break into the ultra-lucrative market for weight-loss medicines.

Medicine 317

Medicine Marketing Drugs 317

Bio Pharma Dive

NOVEMBER 21, 2024

Howard Chang will take over as chief scientific officer and senior VP of research as the biotech searches for more ways to overcome the looming loss of exclusivity for some of its top-selling medicines.

Scientist 316

Scientist Medicine Research 316

Bio Pharma Dive

SEPTEMBER 23, 2024

With fresh, positive data in hand, Biohaven now believes its medicine could be the first to receive FDA approval for spinocerebellar ataxia.

FDA Approval 301

FDA Approval Medicine Drugs 301